<VariationArchive VariationID="495844" VariationName="NM_000377.3(WAS):c.1271dup (p.Leu425fs)" VariationType="Duplication" Accession="VCV000495844" Version="9" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2018-03-17" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="488054" VariationID="495844">
      <GeneList>
        <Gene Symbol="WAS" FullName="WASP actin nucleation promoting factor" GeneID="7454" HGNC_ID="HGNC:12731" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48676636" stop="48691427" display_start="48676636" display_stop="48691427" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542185" stop="48549817" display_start="48542185" display_stop="48549817" Strand="+" />
          </Location>
          <OMIM>300392</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000377.3(WAS):c.1271dup (p.Leu425fs)</Name>
      <CanonicalSPDI>NC_000023.11:48688994:GGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48688994" stop="48688995" display_start="48688994" display_stop="48688995" variantLength="1" positionVCF="48688994" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48547383" stop="48547384" display_start="48547383" display_stop="48547384" variantLength="1" positionVCF="48547383" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>L425fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48547388dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48547388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.48688999dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.48688999dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007877.1" sequenceAccession="NG_007877" sequenceVersion="1" change="g.10203dup">
            <Expression>NG_007877.1:g.10203dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.3" sequenceAccession="NM_000377" sequenceVersion="3" change="c.1271dup" MANESelect="true">
            <Expression>NM_000377.3:c.1271dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000368.1" sequenceAccession="NP_000368" sequenceVersion="1" change="p.Leu425fs">
            <Expression>NP_000368.1:p.Leu425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.2" sequenceAccession="NM_000377" sequenceVersion="2" change="c.1271dupG">
            <Expression>NM_000377.2:c.1271dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.3" sequenceAccession="NM_000377" sequenceVersion="3" change="c.1266_1267insG" MANESelect="true">
            <Expression>NM_000377.3:c.1266_1267insG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_125" sequenceAccession="LRG_125">
            <Expression>LRG_125:g.10203dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_125t1" sequenceAccession="LRG_125t1">
            <Expression>LRG_125t1:c.1271dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_125p1" sequenceAccession="LRG_125p1" change="p.Leu425fs">
            <Expression>LRG_125p1:p.Leu425fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658684302" DB="ClinGen" />
        <XRef Type="rs" ID="1557007312" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000377.3(WAS):c.1271dup (p.Leu425fs) AND Wiskott-Aldrich syndrome" Accession="RCV000590506" Version="1">
        <ClassifiedConditionList TraitSetID="3075">
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-08-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000377.3(WAS):c.1271dup (p.Leu425fs) AND Thrombocytopenia 1" Accession="RCV001009627" Version="1">
        <ClassifiedConditionList TraitSetID="3076">
          <ClassifiedCondition DB="MedGen" ID="C1839163">Thrombocytopenia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-02-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000377.3(WAS):c.1271dup (p.Leu425fs) AND multiple conditions" Accession="RCV001056670" Version="8">
        <ClassifiedConditionList TraitSetID="11545">
          <ClassifiedCondition DB="MedGen" ID="C1839163">Thrombocytopenia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1845987">X-linked severe congenital neutropenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-09" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-03-17" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11442475</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12727931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14504083</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24210885</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8528198</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11545" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5640" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked severe congenital neutropenia</ElementValue>
                <XRef ID="MONDO:0010294" DB="MONDO" />
                <XRef ID="718882006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLN</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SCNX</ElementValue>
                <XRef Type="MIM" ID="300299" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3981" />
                <XRef ID="3981" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="86788" DB="Orphanet" />
              <XRef ID="C1845987" DB="MedGen" />
              <XRef ID="MONDO:0010294" DB="MONDO" />
              <XRef Type="MIM" ID="300299" DB="OMIM" />
            </Trait>
            <Trait ID="6046" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">X-linked thrombocytopenia with normal platelets</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">THROMBOCYTOPENIA, X-LINKED, 1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombocytopenia, X-linked</ElementValue>
                <XRef ID="Thrombocytopenia%2C+x-linked/7084" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Thrombocytopenia 1</ElementValue>
                <XRef ID="MONDO:0010743" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS/XLT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLT</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5176" />
                <XRef ID="5176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="268322" DB="Orphanet" />
              <XRef ID="852" DB="Orphanet" />
              <XRef ID="C1839163" DB="MedGen" />
              <XRef ID="MONDO:0010743" DB="MONDO" />
              <XRef Type="MIM" ID="313900" DB="OMIM" />
            </Trait>
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3075" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3076" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6046" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">X-linked thrombocytopenia with normal platelets</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">THROMBOCYTOPENIA, X-LINKED, 1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300392.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombocytopenia, X-linked</ElementValue>
                <XRef ID="Thrombocytopenia%2C+x-linked/7084" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Thrombocytopenia 1</ElementValue>
                <XRef ID="MONDO:0010743" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS/XLT</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC1</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLT</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">THC</ElementValue>
                <XRef Type="MIM" ID="313900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">WAS-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5176" />
                <XRef ID="5176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="268322" DB="Orphanet" />
              <XRef ID="852" DB="Orphanet" />
              <XRef ID="C1839163" DB="MedGen" />
              <XRef ID="MONDO:0010743" DB="MONDO" />
              <XRef Type="MIM" ID="313900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1362991" SubmissionDate="2018-01-25" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_000377.2:c.1271dupG|MedGen:C0043194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000696639" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12727931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24210885</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11442475</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14504083</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8528198</ID>
          </Citation>
          <Comment>Variant summary: The WAS c.1271dupG (p.Leu425Profs) variant results in a premature termination codon, predicted to cause a truncated or absent WAS protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as likely pathogenic by our laboratory (e.g. c.1352delC, p.Pro451fs). MutationTaster predicts a damaging outcome for this variant. Functional studies showed absent or very low WASP protein levels in PBMCs and T lymphocytes derived from Wiskott-Aldrich syndrome patients (Qasim_2001, Wada_2003). This variant was not found in the large control database ExAC in 30090 control chromosomes and was found in several male patients with Wiskott-Aldrich syndrome (Qasim_2001, Wada_2003, Kolluri_1995, Simon_2014). Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000377.2:c.1271dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043194" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2307732" SubmissionDate="2020-03-11" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="SUB6971170" submittedAssembly="GRCh37" title="SUB6971170" />
        <ClinVarAccession Accession="SCV001161677" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A hemizygous single base pair deletion in exon 10 of the WAS gene that results in a frameshift and premature truncation of the protein 70 amino acids downstream to codon 425 was detected. The observed variant c.1266_1267insG (p.Leu425ProfsTer) has not been reported in the 1000 Genomes and ExAC databases. The in silico prediction of the variant is damaging by MutationTaster2. The observed variant has previously been reported in patients affected with thrombocytopenia (Kolluri et al 1995) and has been reported as pathogenic in ClinVar database. The reference codon is conserved across primates. In summary, the variant meets our criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Indian Hindu</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2019-12-10" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0040186" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0100806" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001873" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000122" />
              </Trait>
              <Comment>Sudden apnea and bradychardia on day 8 of life and died.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS">
              <Name>WASP actin nucleation promoting factor</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000377.3:exon 10</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-4979</Name>
            <Name>p.Leu425ProfsTer70</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="rs1557007312" />
          </XRefList>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_000377.3:c.1266_1267insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="313900" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6971170</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2386574" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4971372|MedGen:C0043194;C1845987;C1839163" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001221124" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8528198</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11442475</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12727931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24210885</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11442475</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12727931</ID>
          </Citation>
          <Comment>This sequence change results in a premature translational stop signal in the WAS gene (p.Leu425Profs*70). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 78 amino acids of the WAS protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals and families affected with¬†Wiskott-Aldrich syndrome¬†(PMID: 8528198, 11442475, 12727931, 24210885).¬†This variant is also known as G insertion after G13O5, 1271insG, and 1305insG in the literature.¬†ClinVar contains an entry for this variant (Variation ID:¬†495844). This variant has been reported to affect WAS protein function (PMID: 11442475, 12727931). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.48547383_48547384insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043194" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845987" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839163" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2307732" TraitType="Disease" MappingType="XRef" MappingValue="313900" MappingRef="OMIM">
        <MedGen CUI="C1839163" Name="Thrombocytopenia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2386574" TraitType="Disease" MappingType="XRef" MappingValue="C0043194" MappingRef="MedGen">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1362991" TraitType="Disease" MappingType="XRef" MappingValue="C0043194" MappingRef="MedGen">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307732" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000122" MappingRef="HP">
        <MedGen CUI="C0266294" Name="Unilateral renal agenesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2386574" TraitType="Disease" MappingType="XRef" MappingValue="C1845987" MappingRef="MedGen">
        <MedGen CUI="C1845987" Name="X-linked severe congenital neutropenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307732" TraitType="Finding" MappingType="XRef" MappingValue="HP:0040186" MappingRef="HP">
        <MedGen CUI="C0423791" Name="Maculopapular exanthema" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307732" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001873" MappingRef="HP">
        <MedGen CUI="C0040034" Name="Thrombocytopenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2386574" TraitType="Disease" MappingType="XRef" MappingValue="C1839163" MappingRef="MedGen">
        <MedGen CUI="C1839163" Name="Thrombocytopenia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2307732" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100806" MappingRef="HP">
        <MedGen CUI="C0036690" Name="Sepsis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

